CHRISTY RIDDLE: Open Payments
NPI 1790918951 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,130 in 143 payments from 16 companies in 2025. Trend: 2023 $549 · 2024 $1,602 · 2025 $2,130
Food & beverage: $2,055Education: $75
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 39 | $529 |
| Alkermes, Inc. | 27 | $336 |
| Teva Pharmaceuticals USA, Inc. | 11 | $219 |
| Supernus Pharmaceuticals, Inc. | 9 | $166 |
| Vanda Pharmaceuticals Inc. | 13 | $163 |
| Collegium Pharmaceutical, Inc. | 13 | $159 |
| Indivior Inc. | 9 | $147 |
| Neurocrine BioSciences, Inc. | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $60 |
Products named: REXULTI, ARISTADA, Qelbree, Jornay PM, FANAPT, SUBLOCADE, INGREZZA, ABILIFY MAINTENA.
Industry payments across IN — which companies pay providers there.
